Company Overview
Company Name
Denali Therapeutics
Address
161 Oyster Point Blvd- South, San Francisco, CA, 94080, United States
Website
dnli.comAbout Denali Therapeutics
Denali Therapeutics is a biopharmaceutical company based in San Francisco, California, focused on developing treatments for neurodegenerative and lysosomal storage diseases. The company leverages recent scientific advancements to discover and develop effective molecular therapeutics targeting genetic causes and biological processes underlying these debilitating conditions.
Frequently Asked Questions about Denali Therapeutics
Technologies Used
Key Decision Makers
Malia Koons Sr. Clinical Trial Manager